Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab + FOLFIRI in KRAS/NRAS wild-type metastatic colorectal cancer
NCT01814501Phase 2Completed
- Sponsor
- Hays
- Start
- Feb 2013
- Primary completion
- Aug 2018
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in colorectal cancer (metastatic) (mCRC), sponsored by Hays. Started Feb 2013; status: completed.
02
Drugs
panitumumab
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT01814501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01814501.